Norway -
Norwegian -
Statens legemiddelverk
klacid 25 mg/ ml
mylan healthcare norge as - klaritromycin - granulat til mikstur, suspensjon - 25 mg/ ml
Norway -
Norwegian -
Statens legemiddelverk
klacid 50 mg/ ml
mylan healthcare norge as - klaritromycin - granulat til mikstur, suspensjon - 50 mg/ ml
Norway -
Norwegian -
Statens legemiddelverk
klacid od 500 mg
viatris as - klaritromycin - depottablett - 500 mg
Norway -
Norwegian -
Statens legemiddelverk
migard 2.5 mg
menarini international o.l. s.a. - frovatriptan - tablett, filmdrasjert - 2.5 mg
Norway -
Norwegian -
Statens legemiddelverk
sumatriptan aristo 50 mg
aristo pharma gmbh - sumatriptansuksinat - tablett - 50 mg
Norway -
Norwegian -
Statens legemiddelverk
sumatriptan aristo 100 mg
aristo pharma gmbh - sumatriptansuksinat - tablett - 100 mg
Norway -
Norwegian -
Statens legemiddelverk
sumatriptan bluefish 50 mg
bluefish pharmaceuticals ab - sumatriptansuksinat - tablett - 50 mg
Norway -
Norwegian -
Statens legemiddelverk
sumatriptan bluefish 100 mg
bluefish pharmaceuticals ab - sumatriptansuksinat - tablett - 100 mg
European Union -
Norwegian -
EMA (European Medicines Agency)
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale midler til systemisk bruk - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
European Union -
Norwegian -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.